Influenza Vaccination as Secondary Prevention for Cardiovascular Disease: A Science Advisory From the American Heart Association/American College of Cardiology
- 3 October 2006
- journal article
- practice guideline
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 48 (7), 1498-1502
- https://doi.org/10.1016/j.jacc.2006.09.004
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Low Prevalence of Influenza Vaccination Among People with Cardiovascular Disease—BRFSSAmerican Journal of Preventive Medicine, 2005
- Delivery of Influenza Vaccine to Nonelderly Persons with Cardiovascular Disease, with Varying National Supply of Vaccine: A Decision AnalysisHuman Vaccines, 2005
- Autoimmune Nature of Influenza AtherogenicityAnnals of the New York Academy of Sciences, 2005
- Risk of Myocardial Infarction and Stroke after Acute Infection or VaccinationThe New England Journal of Medicine, 2004
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004
- National availability of influenza vaccine among medical subspecialty practicesAmerican Journal of Preventive Medicine, 2004
- Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study One-year follow-upEuropean Heart Journal, 2004
- A national survey of physician practices regarding influenza vaccineJournal of General Internal Medicine, 2002
- Influenza Vaccine Pilot Study in Acute Coronary Syndromes and Planned Percutaneous Coronary InterventionsCirculation, 2002
- Association Between Influenza Vaccination and Reduced Risk of Brain InfarctionStroke, 2002